Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Ross

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226Ronald N Jones, Kelley A Fedler, Nicole E Scangarella-Oman, et al.
Journal of Clinical Microbiology|September 16, 2011
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitorJames E Ross, Nicole E Scangarella-Oman, Linda A Miller, et al.
Journal of Clinical Microbiology|May 24, 2013
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agentsRodrigo E Mendes, Lalitagauri M Deshpande, Jihye Kim, et al.
Journal of Clinical Microbiology|June 4, 2010
First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilizationRodrigo E Mendes, Lalitagauri Deshpande, Eduardo Rodriguez-Noriega, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Journal of Chemotherapy (Florence, Italy)|November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countriesRobert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|November 17, 2009
Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008Ronald N Jones, James E Ross, Jan M Bell, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance programRobert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2013
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011Ronald N Jones, Teri Glick, Helio S Sader, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226Ronald N Jones, Kelley A Fedler, Nicole E Scangarella-Oman, et al.
Journal of Clinical Microbiology|September 16, 2011
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitorJames E Ross, Nicole E Scangarella-Oman, Linda A Miller, et al.
Journal of Clinical Microbiology|May 24, 2013
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agentsRodrigo E Mendes, Lalitagauri M Deshpande, Jihye Kim, et al.
Journal of Clinical Microbiology|June 4, 2010
First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilizationRodrigo E Mendes, Lalitagauri Deshpande, Eduardo Rodriguez-Noriega, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Journal of Chemotherapy (Florence, Italy)|November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countriesRobert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|November 17, 2009
Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008Ronald N Jones, James E Ross, Jan M Bell, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance programRobert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2013
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011Ronald N Jones, Teri Glick, Helio S Sader, et al.
Pageof 4